LncRNA DEPDC1-AS1 drives the progression of endometrial carcinoma by regulating miR-508-3p
Discover Oncology · 26.09.2025 · 16 (1)
DOI: 10.1007/s12672-025-03417-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 26.09.2025. Verfasst von Rencheng Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Renhe Hospital, No. 1999, Changjiang West Road, Baoshan District, Shanghai, 200431, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: Endometrial carcinoma (EC) ranks among the three most prevalent malignant tumors affecting the female reproductive system. DEPDC1-AS1 is a newly identified lncRNA, and its mechanism of action in EC remains to be explored. METHODS: 100 hyperplasia and 100 EC patients were included. The abundance of DEPDC1-AS1, miR-508-3p, and SQSTM1 was quantified by qRT-PCR. Kaplan-Meier survival curve and Cox regression predicted prognostic factors. Pearson correlation was used to assess the relationships among the molecular markers. Cell proliferation was assessed with the CCK-8 assay, and migration/invasion with Transwell assays. The regulatory interactions were predicted by bioinformatics and validated through dual-luciferase reporter assays and co-transfection experiments. RESULTS: DEPDC1-AS1 was enhanced in EC tissues and cell lines and identified as an independent prognostic factor. Its expression was associated with FIGO stage and cervical invasion, while lower DEPDC1-AS1 levels correlated with improved survival outcomes. Functional experiments showed that silencing DEPDC1-AS1 inhibited EC cell proliferation, migration, and invasion. Mechanistically, DEPDC1-AS1 sponges miR-508-3p, with a confirmed negative correlation between the two. DEPDC1-AS1 promoted EC cell aggressiveness by modulating miR-508-3p, which directly targets SQSTM1. SQSTM1 expression was negatively correlated with miR-508-3p and positively correlated with DEPDC1-AS1. CONCLUSION: DEPDC1-AS1 may serve as a promising prognostic biomarker in EC. These findings suggest that DEPDC1-AS1 facilitates EC progression through the miR-508-3p, highlighting its potential as a therapeutic target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Renhe Hospital, No. 1999, Changjiang West Road, Baoshan District, Shanghai, 200431, China.
- Department of Obstetrics and Gynecology, Renhe Hospital, No. 1999, Changjiang West Road, Baoshan District, Shanghai, 200431, China. Jianhuajidr@163.com.
Zitieren
APA
Wang, R., & Ji, J. (2025). LncRNA DEPDC1-AS1 drives the progression of endometrial carcinoma by regulating miR-508-3p. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03417-y
Vancouver
Wang R, Ji J. LncRNA DEPDC1-AS1 drives the progression of endometrial carcinoma by regulating miR-508-3p. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-03417-y
BibTeX
@article{Wang2025,
author = {Wang, Rencheng and Ji, Jianhua},
title = {LncRNA DEPDC1-AS1 drives the progression of endometrial carcinoma by regulating miR-508-3p},
journal = {Discover Oncology},
year = {2025},
volume = {16},
number = {1},
doi = {10.1007/s12672-025-03417-y}
}
EUVIMED